Professor Pat Price is an academic clinical oncologist specialising in PET based molecular imaging, advanced radiotherapy techniques and translational research in oncology.

Currently Professor Price is a visiting Professor in the Division of Surgery within the Department of Surgery and Cancer, Imperial College London.

Prof Price pioneered the use of PET molecular imaging for micro-dosing pharmacokinetic and pharmacokinetic studies of new cancer agents and has one of the best insights into the potential of the application of this technology for oncology drug development. Through the PET Research Advisory Company www.the-pra.co.uk, she provides advice to organisations on current and projected future investments in PET.

Professor Pat Price studied at Cambridge and King’s College Hospital Medical School. She trained in general medicine in Cambridge and in oncology at the Royal Marsden Hospital. She took a research position under a Cancer Research Campaign Clinical Fellowship at the Institute of Cancer Research, London, and won the Cambridge University prize for best laboratory based MD. She went on to work at the Hammersmith Hospital, London as a Senior Lecturer.

While at the Hammersmith she developed a research interest in molecular imaging for oncology. Professor Price pioneered the use of PET imaging to investigate how cancer drugs move in the body and the effect they have. She set up and headed the Medical Research Council and Cancer Research Campaign Positron Emission Tomography (PET) Oncology Programmes. She moved to Manchester in September 2000 to take up the Ralston Paterson Chair in Radiation Oncology and set up the new Wolfson Molecular Imaging Centre at the Christie Hospital.

Professor Price is a member of the American Association for Cancer Research (AACR) membership Development Committee. She is a member of a number of Cancer Research UK committees, and the Royal College of Radiologists Radiotherapy Development Board.

Previously she was president of the British Oncological Association and sits on the 2008 RAE sub-committee for Cancer. She established and chaired for 6 years, the European Organisation for Research and Treatment of Cancer (EORTC) Functional Imaging Group, and in 2005 established the UK National Cancer Research Institute (NCRI) Academic Clinical Oncology and Radiobiology Research Network (ACORRN) which aims to reinvigorate radiotherapy and radiobiology research in the UK. She has over 140 peer reviewed research publications and co-edits the UK standard oncology text book Treatment of Cancer.